WI
GILD icon

Welch Investments’s Gilead Sciences GILD Stock Holding History

Welch Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$110K Buy
1,536
+198
+15% +$15K 0.07% 53
2017
Q3 		$108K Buy
+1,338
New +$102K 0.07% 46

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Welch Investments's GILD Position: Q4 2017 in Review

Welch Investments increased its Gilead Sciences (GILD) stake by 15% in Q4 2017, buying an estimated $15K and bringing the position to 1,536 shares worth $110K. The position accounts for 0.07% of the portfolio, ranked #53.

Welch Investments first reported a position in GILD in Q3 2017 and has held it in 2 quarters since. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Welch Investments held 1,536 shares of Gilead Sciences worth $110K as of Q4 2017.
  • Welch Investments bought 198 Gilead Sciences shares in Q4 2017, an estimated $15K.
  • Gilead Sciences made up 0.07% of Welch Investments's portfolio in Q4 2017, its #53 holding.
  • Welch Investments first reported a position in Gilead Sciences in Q3 2017 and has held it in 2 quarters since.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Welch Investments's 13F filing for Q4 2017, filed 30 Jan 2018.